文献速递泌尿生殖US

高频定量超声联合新型微超声扫描仪用于前列腺癌成像

High-Frequency Quantitative Ultrasound for Imaging Prostate Cancer Using a Novel Micro-Ultrasound Scanner.
PubMed 文献 · Ultrasound Med Biol · 2018-04-04

本研究使用29 MHz经直肠微超声系统在163例患者12针穿刺活检前采集射频数据,共1956针芯,训练线性判别分类器和支持向量机区分前列腺癌。基于频谱定量超声参数与包络统计的联合模型最佳AUC达0.81,提示该用户非依赖性工具在前列腺癌风险评估中具有潜力。

要点

  • 29 MHz微超声射频数据训练的定量超声分类器区分前列腺癌最佳AUC为0.81。
  • 有效散射直径与有效声浓度联合线性判别分类器AUC为0.77。
  • 加用Nakagami-µ或PSA后AUC升至0.79,联合包络统计与PSA等可达0.81。

核心结论

  • 基于29 MHz微超声的定量超声参数联合模型在前列腺癌分类中AUC达0.81,初步结果对开发以用户非依赖性为主的前列腺癌风险评估工具具有鼓励意义。

研究设计与样本

  • 回顾性数据来自正在进行的多中心2000例随机临床试验(NCT02079025)的子集,纳入163例患者共1956针芯,在12针穿刺活检前用29 MHz经直肠微超声系统(ExactVu,Exact Imaging,Markham,Canada)采集射频数据。

诊断标准与关键数值

  • 有效散射直径与有效声浓度联合线性判别分类器AUC为0.77;加用Nakagami-µ或PSA后AUC升至0.79;支持向量机联合包络与频谱定量超声估计AUC为0.77;线性判别分类器联合包络统计、PSA、有效散射直径和有效声浓度AUC为0.81;10折交叉验证的ROC分析评估分类器性能;既往研究中PRI-MUS方案B模式评分由专家判读对Gleason评分>7的最大AUC为0.74。

临床应用与阅片要点

  • 作者认为AUC 0.81的初步结果对开发以用户非依赖性为主的前列腺癌风险评估工具具有鼓励意义。

局限性

  • 这些回顾性数据是正在进行的多中心2000例随机临床试验数据的子集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Currently, biopsies guided by transrectal ultrasound (TRUS) are the only method for definitive diagnosis of prostate cancer. Studies by our group suggest that quantitative ultrasound (QUS) could provide a more sensitive means of targeting biopsies and directing focal treatments to cancer-suspicious regions in the prostate. Previous studies have utilized ultrasound signals at typical clinical frequencies, i.e., in the 6-MHz range. In the present study, a 29-MHz, TRUS, micro-ultrasound system and transducer (ExactVu micro-ultrasound, Exact Imaging, Markham, Canada) was used to acquire radio frequency data from 163 patients immediately before 12-core biopsy procedures, comprising 1956 cores. These retrospective data are a subset of data acquired in an ongoing, multisite, 2000-patient, randomized, clinical trial (clinicaltrials.gov NCT02079025). Spectrum-based QUS estimates of effective scatter diameter (ESD), effective acoustic concentration (EAC), midband (M), intercept (I) and slope (S) as well as envelope statistics employing a Nakagami distribution were used to train linear discriminant classifiers (LDCs) and support vector machines (SVMs). Classifier performance was assessed using area-under-the-curve (AUC) values obtained from receiver operating characteristic (ROC) analyses with 10-fold cross validation. A combination of ESD and EAC parameters resulted in an AUC value of 0.77 using a LDC. When Nakagami-µ or prostate-specific antigen (PSA) values were added as features, the AUC value increased to 0.79. SVM produced an AUC value of 0.77, using a combination of envelope and spectral QUS estimates. The best classification produced an AUC value of 0.81 using an LDC when combining envelope statistics, PSA, ESD and EAC. In a previous study, B-mode-based scoring and evaluation using the PRI-MUS protocol produced a maximal AUC value of 0.74 for higher Gleason-score values (GS >7) when read by an expert. Our initial results with AUC values of 0.81 are very encouraging for developing a new, predominantly user-independent, prostate-cancer, risk-assessing tool.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Rohrbach D, Wodlinger B, Wen J, et al. High-Frequency Quantitative Ultrasound for Imaging Prostate Cancer Using a Novel Micro-Ultrasound Scanner. Ultrasound Med Biol. 2018. PMID: 29627083. doi:10.1016/j.ultrasmedbio.2018.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。